1,3-dipropyl-8-cyclopentylxanthine has been researched along with lithium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buxton, IL; Doggwiler, KO; Schiemann, WP | 1 |
| Alexander, SP; Hill, SJ; Kendall, DA | 1 |
| Bowmer, CJ; Knight, RJ; Yates, MS | 1 |
| Li, H; Li, YQ; Wu, L | 1 |
4 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and lithium
| Article | Year |
|---|---|
Action of adenosine in estrogen-primed nonpregnant guinea pig myometrium: characterization of the smooth muscle receptor and coupling to phosphoinositide metabolism.
Topics: Adenosine; Animals; Estrogens; Female; Guinea Pigs; Inositol; Lithium; Muscle, Smooth; Myometrium; Phenylisopropyladenosine; Phosphatidylinositols; Prostaglandins; Receptors, Purinergic; Xanthines | 1991 |
Differences in the adenosine receptors modulating inositol phosphates and cyclic AMP accumulation in mammalian cerebral cortex.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cerebral Cortex; Colforsin; Cyclic AMP; Female; Guinea Pigs; In Vitro Techniques; Inositol Phosphates; Kinetics; Lithium; Male; Mice; Receptors, Purinergic; Second Messenger Systems; Xanthines | 1989 |
The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.
Topics: Animals; Blood Pressure; Body Water; Chlorides; Diuretics; Injections, Intravenous; Inulin; Lithium; Male; p-Aminohippuric Acid; Potassium; Purinergic Antagonists; Rats; Rats, Brattleboro; Rats, Wistar; Sodium; Xanthines | 1993 |
Adenosine suppresses the response of neurons to gaba in the superficial laminae of the rat spinal dorsal horn.
Topics: Adenosine; Alkaloids; Analgesics; Animals; Animals, Newborn; Benzophenanthridines; Bicuculline; Chelating Agents; Diglycerides; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Conductivity; Enzyme Inhibitors; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Isoquinolines; Lithium; Membrane Potentials; Muscimol; Neural Inhibition; Patch-Clamp Techniques; Phenanthridines; Posterior Horn Cells; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Sulfonamides; Xanthines | 2003 |